The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis (original) (raw)

References

  1. Park, J.B., Rhim, J.S., Park, S.C., Kimm, S. W. & Kraus, M.H. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res. 49, 6605–6609 (1989).
    CAS Google Scholar
  2. Schneider, P.M. et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res. 49, 4968–71 (1989).
    CAS Google Scholar
  3. Weiner, D.B. et al. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res. 50, 421–5 (1990).
    CAS Google Scholar
  4. Xia, W., Lau, Y.K., Zhang, H.Z. & Hung, M.-C. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin. Cancer Res. 3, 3–9 (1997).
    CAS Google Scholar
  5. Yokota, J. et al. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2, 283–287 (1988).
    CAS Google Scholar
  6. Shi, D. et al. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. Mol. Carcinog. 5, 213–218 (1992).
    Article CAS Google Scholar
  7. D'Emilia, J. et al. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 4, 1233–1239 (1989).
    CAS Google Scholar
  8. Slamon, D.J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177–182 (1987).
    Article CAS Google Scholar
  9. Slamon, D.J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712 (1989).
    Article CAS Google Scholar
  10. Zhang, X., Silva, E., Gershenson, D. & Hung, M.C. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Oncogene 4, 985–989 (1989).
    CAS Google Scholar
  11. Berchuck, A. et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50, 4087–4091 (1990).
    CAS Google Scholar
  12. Yu, D. & Hung, M.C. The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A. Cancer Metast. Rev. 17, 195–202 (1998).
    Article CAS Google Scholar
  13. Chazin, V.R., Kaleko, M., Miller, A.D. & Slamon, D.J. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. Oncogene 7, 1859–1866 (1992).
    CAS Google Scholar
  14. Yu, D.H. & Hung, M.-C. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6, 1991–1996 (1991).
    CAS Google Scholar
  15. Yu, D. et al. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res. 54, 3260–3266 (1994).
    CAS Google Scholar
  16. Benz, C.C. et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24, 85–95 (1993).
    Article CAS Google Scholar
  17. Tan, M., Yao, J. & Yu, D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 57, 1199–1205 (1997).
    CAS Google Scholar
  18. Hudziak, R.M. et al. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 85, 5102–5106 (1988).
    Article CAS Google Scholar
  19. Tsai, C.M. et al. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J. Natl. Cancer Inst. 85, 897–901 (1993).
    Article CAS Google Scholar
  20. Tsai, C.M. et al. Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells. J. Natl. Cancer Inst. 87, 682–684 (1995).
    Article CAS Google Scholar
  21. Yu, D. et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Molecular Cell 2, 581–591 (1998).
    Article CAS Google Scholar
  22. Yu, D. et al. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. Oncogene 16, 2087–2094 (1998).
    Article CAS Google Scholar
  23. Yu, D., Suen, T.C., Yan, D.H., Chang, L.S. & Hung, M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc. Natl. Acad. Sci. USA 87, 4499–4503 (1990).
    Article CAS Google Scholar
  24. Yu, D., Hamada, J., Zhang, H., Nicolson, G.L. & Hung, M.C. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene 7, 2263–2270 (1992).
    CAS Google Scholar
  25. Yu, D., Suen, T.C., Yan, D.H., Chang, L.S. & Hung, M.C. Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Oncogene 7, 2263–2270 (1992).
    CAS Google Scholar
  26. Zhang, Y., Yu, D., Xia, W. & Hung, M.C. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model. Oncogene 10, 1947–1954 (1995).
    CAS Google Scholar
  27. Xing, X. et al. Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Cancer Gene Ther. 3, 168–174 (1996).
    CAS Google Scholar
  28. Chen, H. & Hung, M.-C. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene. J. Biol. Chem. 272, 6101–6104 (1997).
    Article CAS Google Scholar
  29. Yu, D. et al. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Oncogene 11, 1383–1388 (1995).
    CAS Google Scholar
  30. Hung, M.C. et al. HER-2/neu-targeting gene therapy—a review. Gene 159, 65–71 (1995).
    Article CAS Google Scholar
  31. Xin, J.H., Cowie, A., Lachance, P. & Hassell, J.A. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryo cells. Genes Dev. 6, 481–496 (1992).
    Article CAS Google Scholar
  32. Tal, M. et al. Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol. Cell Biol. 7, 2597–2601 (1987).
    Article CAS Google Scholar
  33. White, M.R. & Hung, M.C. Cloning and characterization of the mouse neu promoter. Oncogene 7, 677–683 (1992).
    CAS Google Scholar
  34. Buttice, G. & Kurkinen, M. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysine gene. J. Biol. Chem. 268, 7196–2704 (1993).
    CAS Google Scholar
  35. Zhang, M., Magit, D. & Sager, R. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc. Natl. Acad. Sci. USA 94, 5673–5678 (1997).
    Article CAS Google Scholar
  36. Zhang, M., Maass, N., Magit, D. & Sager, R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Different. 8, 179–186 (1997).
    CAS Google Scholar
  37. Sgouras, D.N. et al. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J. 14, 4781–4793 (1995).
    Article CAS Google Scholar
  38. Giovane, A., Pintzas, A., Maira, S. M., Sobieszczuk, P. & Wasylyk, B. Net, a new ets transcription factor that is activated by Ras. Genes Dev. 8, 1502–1513 (1994).
    Article CAS Google Scholar
  39. Chen, H.M. & Boxer, L.M. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol. Cell. Biol. 15, 3840–7 (1995).
    Article CAS Google Scholar
  40. Goldberg, Y., Treier, M., Ghysdael, J. & Bohmann, D. Repression of AP-1-stimulated transcription by c-Ets-1. J. Biol. Chem. 269, 16566–16573 (1994).
    CAS Google Scholar
  41. Benz, C.C. et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15, 1513–1525 (1997).
    Article CAS Google Scholar
  42. Gluzman, Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175–182 (1981).
    Article CAS Google Scholar
  43. Baselga, J., Norton, L., Albanell, J., Kim, Y.M. & Mendelsohn, J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825–2831 (1998).
    CAS Google Scholar
  44. Pegram, M.D. et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol. 16, 2659–2671 (1998).
    Article CAS Google Scholar
  45. Chang, J.Y. et al. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Oncogene 14, 561–568 (1997).
    Article CAS Google Scholar
  46. Hung, M.-C., Wang, S.-C. & Hortobagyi, G. (eds.) Targeting HER-2/neu-Overexpressing Cancer Cells with Transcriptional Repressor Genes Delivered by Cationic Liposome (Academic Press, San Diego, CA, 1999).
    Book Google Scholar
  47. Baert, J.L. et al. Expression of the PEA3 group of EST-related transcription factors in human breast cancer cells. Int. J. Cancer 70, 590–597 (1997).
    Article CAS Google Scholar
  48. Bold, R.J. & Donoghue, D.J. Biologically active mutants with deletion in the v-mos oncogene assayed with retroviral vectors. Mol. Cell. Biol. 5, 3131–3138 (1985).
    Article CAS Google Scholar

Download references